tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mesoblast reports Q2 Ryoncil revenue up 66% y/y
PremiumThe FlyMesoblast reports Q2 Ryoncil revenue up 66% y/y
16d ago
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
Premium
The Fly
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
20d ago
Mesoblast’s Ryoncil® Gains Medicare & Medicaid J-Code for Enhanced Access
Premium
Company Announcements
Mesoblast’s Ryoncil® Gains Medicare & Medicaid J-Code for Enhanced Access
20d ago
Mesoblast Highlights Successful Launch of Ryoncil® at Global Conferences
PremiumCompany AnnouncementsMesoblast Highlights Successful Launch of Ryoncil® at Global Conferences
1M ago
Mesoblast Director Increases Stake with Significant Share Acquisition
Premium
Company Announcements
Mesoblast Director Increases Stake with Significant Share Acquisition
1M ago
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
Premium
Ratings
Buy Rating for Mesoblast Driven by Strong Ryoncil Launch and Strategic Financial Moves
2M ago
Mesoblast falls -12.5%
PremiumThe FlyMesoblast falls -12.5%
2M ago
Mesoblast Limited Reports Progress and Financial Challenges
Premium
Company Announcements
Mesoblast Limited Reports Progress and Financial Challenges
2M ago
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
Premium
The Fly
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100